CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,405,083 | -18.7% | 87,394 | +0.2% | 0.06% | -14.5% |
| Q2 2023 | $2,959,646 | +1.1% | 87,228 | +7.2% | 0.07% | -19.8% |
| Q1 2023 | $2,927,549 | -19.2% | 81,366 | +0.1% | 0.09% | -15.7% |
| Q4 2022 | $3,624,388 | +58.5% | 81,319 | -0.0% | 0.10% | +52.2% |
| Q3 2022 | $2,287,000 | +248.6% | 81,350 | +234.6% | 0.07% | +272.2% |
| Q2 2022 | $656,000 | -21.4% | 24,316 | -0.8% | 0.02% | -10.0% |
| Q1 2022 | $835,000 | -23.3% | 24,517 | -12.9% | 0.02% | -13.0% |
| Q4 2021 | $1,088,000 | – | 28,158 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |